201 related articles for article (PubMed ID: 1678976)
1. Autologous blood stem cell transplantation versus autologous bone marrow transplantation for acute myeloid leukemia in first complete remission. The EBMT Group Working Party for Autologous Bone Marrow Transplantation.
Reiffers J; Korbling M; Labopin M; Gorin NC
Bone Marrow Transplant; 1991; 7 Suppl 2():144. PubMed ID: 1678976
[No Abstract] [Full Text] [Related]
2. Allogeneic versus autologous bone marrow transplantation versus chemotherapy for treatment of acute myeloid leukemia in first complete remission (BGM 84 and BGMT 87 studies). The BGMT Group.
Reiffers J; Stoppa AM; Rigal-Huguet F; Michallet M; Marit G; Gastaut JA; Attal M; Corront B; Broustet A; Hollard D
Bone Marrow Transplant; 1991; 7 Suppl 2():36. PubMed ID: 1878709
[No Abstract] [Full Text] [Related]
3. Allogeneic and autologous bone marrow transplantation for patients with acute non-lymphoblastic leukemia in first complete remission. The Genoa experience on 119 patients.
Carella AM; Piatti G; Frassoni F; Maraone MP; Van Lint MT; Bacigalupo A
Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():55. PubMed ID: 2202469
[No Abstract] [Full Text] [Related]
4. Autologous bone marrow transplantation in patients with AML in second complete remission (CR).
Meloni G; De Fabritiis P; Amadori S; Petti MC; Pulsoni A; Sandrelli A; Mandelli F
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():207-8. PubMed ID: 2653505
[No Abstract] [Full Text] [Related]
5. Retrospective evaluation of autologous bone marrow transplantation vs allogeneic bone marrow transplantation from an HLA identical related donor in acute myelocytic leukemia. A study of the European Cooperative Group for Blood and Marrow Transplantation (EBMT).
Gorin NC; Labopin M; Fouillard L; Meloni G; Frassoni F; Iriondo A; Brunet Mauri S; Goldstone AH; Harousseau JL; Reiffers J; Esperou-Bourdeau H; Gluckman E
Bone Marrow Transplant; 1996 Jul; 18(1):111-7. PubMed ID: 8832003
[TBL] [Abstract][Full Text] [Related]
6. [Autologous bone marrow transplantation in children with acute leukemia or non-Hodgkin's lymphoma].
Emminger W; Hinterberger W; Emminger-Schmidmeier W; Peters C; Fink FM; Zoubek A; Haas OA; Höcker P; Hawliczek R; Knapp W
Wien Med Wochenschr; 1991; 141(9-10):225-8. PubMed ID: 1683071
[TBL] [Abstract][Full Text] [Related]
7. BAVC regimen in CR AML patients.
Meloni G; Vignetti M; De Fabritiis P; Petti MC; Pinto MR; Testi AM; Vegna ML; Mandelli F
Bone Marrow Transplant; 1991; 7 Suppl 2():134. PubMed ID: 1878679
[No Abstract] [Full Text] [Related]
8. [Comparison of autologous and allogeneic hematopoietic stem cell transplantation for 140 patients with de novo acute leukemia in first complete remission].
Wang HH; Feng SZ; Wang M; Wei JL; Jiang EL; Zhang L; Huang Y; Zhou SY; Liu QG; Qiu LG; Han MZ; Yan WW
Zhonghua Xue Ye Xue Za Zhi; 2004 Jul; 25(7):389-92. PubMed ID: 15355688
[TBL] [Abstract][Full Text] [Related]
9. Acute myeloid leukemia and the position of autologous stem cell transplantation.
Breems DA; Löwenberg B
Semin Hematol; 2007 Oct; 44(4):259-66. PubMed ID: 17961725
[TBL] [Abstract][Full Text] [Related]
10. Autologous stem cell transplantation versus chemotherapy for adult patients with acute myeloid leukemia in first remission: the BGMT Group experience.
Reiffers J; Stoppa AM; Attal M; Michallet M; Marit G; Blaise D; Huguet F; Corront B; Cony-Makhoul P; Montastruc M
Nouv Rev Fr Hematol (1978); 1993 Feb; 35(1):17-9. PubMed ID: 8099731
[TBL] [Abstract][Full Text] [Related]
11. Allogeneic bone marrow transplantation for secondary leukaemia and myelodysplastic syndromes. Leukaemia Working Party of the European Bone Marrow Transplantation Group (EBMTG).
De Witte T; Zwaan F; Hermans J; Vernant J; Kolb H; Vossen J; Lönnqvist B; Beelen D; Ferrant A; Gmür J
Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():38-9. PubMed ID: 2697398
[TBL] [Abstract][Full Text] [Related]
12. Allogeneic bone marrow transplantation for leukemia in Europe: regional differences. Report from the Leukemia Working party of the European Group for Bone Marrow Transplantation.
Gratwohl A; Hermans J; Barrett AJ; Ernst P; Frassoni F; Gahrton G; Granena A; Kolb HJ; Prentice HG; Vernant JP
Bone Marrow Transplant; 1990 Mar; 5(3):159-65. PubMed ID: 2331536
[TBL] [Abstract][Full Text] [Related]
13. Allogenic versus autologous marrow transplantation for patients with acute non lymphoblastic leukemia in first complete remission.
Carella AM; Bacigalupo A
Haematologica; 1990; 75(2):198. PubMed ID: 2358214
[No Abstract] [Full Text] [Related]
14. Use of peripheral blood stem cells for autologous transplantation in acute myeloid leukemia patients allows faster engraftment and equivalent disease-free survival compared with bone marrow cells.
Visani G; Lemoli R; Tosi P; Martinelli G; Testoni N; Ricci P; Motta M; Gherlinzoni F; Leopardi G; Pastano R; Rizzi S; Piccaluga P; Isidori A; Tura S
Bone Marrow Transplant; 1999 Sep; 24(5):467-72. PubMed ID: 10482929
[TBL] [Abstract][Full Text] [Related]
15. The use of bone marrow cells grown in long-term culture for autologous bone marrow transplantation in acute myeloid leukaemia: an update.
Chang J; Morgenstern GR; Coutinho LH; Scarffe JH; Carr T; Deakin DP; Testa NG; Dexter TM
Bone Marrow Transplant; 1989 Jan; 4(1):5-9. PubMed ID: 2647188
[TBL] [Abstract][Full Text] [Related]
16. Allogeneic versus autologous bone marrow transplantation versus intensive post-remission chemotherapy in acute leukaemias.
Bernasconi C; Lazzarino M; Canevari A; Morra E; Castelli G; Brusamolino E; Alessandrino EP; Pagnucco G; Orlandi E; Castagnola C
Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():65-8. PubMed ID: 2697439
[No Abstract] [Full Text] [Related]
17. [Allogenic bone marrow transplantation versus autograft in acute lymphoblastic leukemia, in second remission in 113 children. Results of the Grupo Español de Transplante de Medula Niños (GETMON)].
Badell I; Ortega JJ; Muñoz A; Bureo E; Madero L; Olivé T; Cubells J; Maldonado MS; Baro J; Díaz MA
Sangre (Barc); 1996 Apr; 41(2):101-8. PubMed ID: 9045349
[TBL] [Abstract][Full Text] [Related]
18. Results of syngeneic hematopoietic stem cell transplantation for acute leukemia: risk factors for outcomes of adults transplanted in first complete remission.
Fouillard L; Labopin M; Gratwohl A; Gluckman E; Frassoni F; Beelen DW; Willemze R; Montserrat E; Blaise D; Atienza AI; Sierra J; Santos M; Gorin NC; Rocha V;
Haematologica; 2008 Jun; 93(6):834-41. PubMed ID: 18469352
[TBL] [Abstract][Full Text] [Related]
19. Allogeneic bone marrow transplant or second autograft in patients with acute leukemia who relapse after an autograft. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
Ringdén O; Labopin M; Frassoni F; Sanz G; Demeocq F; Prentice H; Cahn JY; Barbui T; Meloni G; Schaefer U; Reiffers J; Gorin N
Bone Marrow Transplant; 1999 Aug; 24(4):389-96. PubMed ID: 10467328
[TBL] [Abstract][Full Text] [Related]
20. Autologous stem cell transplantation in chronic myelogenous leukemia: a retrospective analysis of the European Group for Bone Marrow Transplantation. Chronic Leukemia Working Party of the EBMT.
Reiffers J; Goldman J; Meloni G; Cahn JY; Gratwohl A
Bone Marrow Transplant; 1994 Sep; 14(3):407-10. PubMed ID: 7994263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
